The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients

B. Erdogan, E. Uzaslan, F. Budak, B. Oral, M. Karadag, D. Ediger, G. Goral, E. Ege, O. Gozu (Bursa, Turkey)

Source: Annual Congress 2004 - Molecular biology and tumoral markers
Session: Molecular biology and tumoral markers
Session type: Thematic Poster Session
Number: 592

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Erdogan, E. Uzaslan, F. Budak, B. Oral, M. Karadag, D. Ediger, G. Goral, E. Ege, O. Gozu (Bursa, Turkey). The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients. Eur Respir J 2004; 24: Suppl. 48, 592

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surface activation molecules and intracellular cytokines in bronchoalveolar lavage (BAL) and blood CD3+ cells in advanced sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 350s
Year: 2002

Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients
Source: Eur Respir J 2002; 19: 472-478
Year: 2002



Expression of Fas antigen on bronchoalveolar lavage cells in sarcoidosis- differences between smokers and nonsmokers
Source: Eur Respir J 2003; 22: Suppl. 45, 177s
Year: 2003

Upregulation of expression of membrane apoptosis signals by bronchoalveolar lavage cells in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002

TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Activation of discoidin domain receptor 1 on CD14 positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

The expression of the chemokine receptors CXCCR3 and CCR4 on T cells reflects the Th2 switch in the bronchoalveolar lavage (BAL) of idiopathic pulmonary fibrosis (IPF) patients
Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Year: 2004


Endosomal Toll-like receptors (TLR3 and 9) are overexpressed in bronchoalveolar lavage fluid of patients with lung cancer: Preliminary results
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients
Source: Eur Respir J 2003; 22: Suppl. 45, 201s
Year: 2003

Concentration of soluble intercellular adhesion molecule ICAM-1 in bronchoalveolar lavage fluid of patients with non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 82s
Year: 2004

Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006

Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Reduced expression of PPAR-alpha in bronchoalveolar lavage CD4+ T cells of sarcoidosis patients
Source: Annual Congress 2011 - T-cell subsets
Year: 2011


Interleukin-1β and interleukin -1 receptor antagonist in serum and bronchoalveolar lavage of patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006

Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Non-compartmentalisation of inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients
Source: Eur Respir J 2005; 26: Suppl. 49, 176s
Year: 2005